Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2019 Filed May 17, 2019 21:10 UTC |
WIERENGA WENDALLDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $10.68 Strike: $10.68 | $213,600.00 |
DisclosureSEC source: 0001061983-19-000040 · edgardoc.xml · derivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-15 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020 Read SEC document |
| May 15, 2019 Filed May 17, 2019 21:08 UTC |
PARSHALL B LYNNEDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $10.68 Strike: $10.68 | $213,600.00 |
DisclosureSEC source: 0001061983-19-000039 · edgardoc.xml · derivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-15 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020 Read SEC document |
| May 15, 2019 Filed May 17, 2019 21:08 UTC |
Kaye Edward M. MDDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $10.68 Strike: $10.68 | $213,600.00 |
DisclosureSEC source: 0001061983-19-000038 · edgardoc.xml · derivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-15 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020 Read SEC document |
| May 15, 2019 Filed May 17, 2019 21:08 UTC |
SMITH SANDFORD DDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $10.68 Strike: $10.68 | $213,600.00 |
DisclosureSEC source: 0001061983-19-000037 · edgardoc.xml · derivative · entry 1 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-15 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020 Read SEC document |
| May 15, 2019 Filed May 17, 2019 21:05 UTC |
Califf RobertDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $10.68 Strike: $10.68 | $213,600.00 |
DisclosureSEC source: 0001061983-19-000032 · edgardoc.xml · derivative · entry 1 Califf Robert · CIK 0001574557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-15 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020 Read SEC document |
| May 15, 2019 Filed May 17, 2019 21:07 UTC |
GAGE L PATRICKDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $10.68 Strike: $10.68 | $213,600.00 |
DisclosureSEC source: 0001061983-19-000035 · edgardoc.xml · derivative · entry 1 GAGE L PATRICK · CIK 0001196903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-15 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020 Read SEC document |
| May 15, 2019 Filed Nov 20, 2019 22:02 UTC |
HENDERSON JOHN TDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $10.68 Strike: $10.68 | $213,600.00 |
DisclosureSEC source: 0001061983-19-000069 · edgardoc.xml · derivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-15 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020 Read SEC document |
| May 02, 2019 Filed May 3, 2019 21:34 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $8.29 | $12,429.75 |
DisclosureSEC source: 0001061983-19-000030 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,567 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| April 04, 2019 Filed Apr 5, 2019 23:11 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $8.31 | $12,465.00 |
DisclosureSEC source: 0001061983-19-000028 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,067 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| March 07, 2019 Filed Mar 8, 2019 21:24 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $5.98 | $8,970.00 |
DisclosureSEC source: 0001061983-19-000026 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,567 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:05 UTC |
Malik Fady IbrahamEVP Research & Development
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 66,075 | $7.14 Strike: $7.14 | $471,775.50 |
DisclosureSEC source: 0001061983-19-000024 · edgardoc.xml · derivative · entry 3 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,075 Underlying: Common Stock · 66,075 shares Expires 2029-02-26 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:05 UTC |
Malik Fady IbrahamEVP Research & Development
|
GrantIncentive Stock Option (right to buy) · Derivative | 13,925 | $7.14 Strike: $7.14 | $99,424.50 |
DisclosureSEC source: 0001061983-19-000024 · edgardoc.xml · derivative · entry 2 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,925 Underlying: Common Stock · 13,925 shares Expires 2029-02-26 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:05 UTC |
Malik Fady IbrahamEVP Research & Development
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-19-000024 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,067 F1 · deemedExecutionDate: This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:05 UTC |
Jaw ChingSVP Finance & CFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 35,732 | $7.14 Strike: $7.14 | $255,126.48 |
DisclosureSEC source: 0001061983-19-000023 · edgardoc.xml · derivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,732 Underlying: Common Stock · 35,732 shares Expires 2029-02-26 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:05 UTC |
Jaw ChingSVP Finance & CFO
|
GrantIncentive Stock Option (right to buy) · Derivative | 14,268 | $7.14 Strike: $7.14 | $101,873.52 |
DisclosureSEC source: 0001061983-19-000023 · edgardoc.xml · derivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,268 Underlying: Common Stock · 14,268 shares Expires 2029-02-26 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:05 UTC |
Jaw ChingSVP Finance & CFO
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-19-000023 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · deemedExecutionDate: This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC |
Cragg DavidSVP Human Resources
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 33,889 | $7.14 Strike: $7.14 | $241,967.46 |
DisclosureSEC source: 0001061983-19-000022 · edgardoc.xml · derivative · entry 3 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,889 Underlying: Common Stock · 33,889 shares Expires 2029-02-26 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC |
Cragg DavidSVP Human Resources
|
GrantIncentive Stock Option (right to buy) · Derivative | 16,111 | $7.14 Strike: $7.14 | $115,032.54 |
DisclosureSEC source: 0001061983-19-000022 · edgardoc.xml · derivative · entry 2 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,111 Underlying: Common Stock · 16,111 shares Expires 2029-02-26 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC |
Cragg DavidSVP Human Resources
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-19-000022 · edgardoc.xml · nonDerivative · entry 1 Cragg David · CIK 0001316459 · SVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,783 F1 · deemedExecutionDate: This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC |
Blum Robert IDirector · President & CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 225,099 | $7.14 Strike: $7.14 | $1,607,206.86 |
DisclosureSEC source: 0001061983-19-000021 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,099 Underlying: Common Stock · 225,099 shares Expires 2029-02-26 F4 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC |
Blum Robert IDirector · President & CEO
|
GrantIncentive Stock Option (right to buy) · Derivative | 14,901 | $7.14 Strike: $7.14 | $106,393.14 |
DisclosureSEC source: 0001061983-19-000021 · edgardoc.xml · derivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,901 Underlying: Common Stock · 14,901 shares Expires 2029-02-26 F4 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| February 26, 2019 Filed Mar 4, 2019 21:04 UTC |
Blum Robert IDirector · President & CEO
|
GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-19-000021 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,022 F1 · deemedExecutionDate: This award shall vest over three years in annual installments: 40% one year from the date of grant, 40% two years from the date of grant and 20% three years from the date of grant. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 21:27 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $7.28 | $10,920.00 |
DisclosureSEC source: 0001061983-19-000017 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,067 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:38 UTC |
SCHLOSSBERG MARK ASVP - Legal & General Counsel
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 55,244 | $7.03 Strike: $7.03 | $388,365.32 |
DisclosureSEC source: 0001061983-19-000015 · edgardoc.xml · derivative · entry 2 SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,244 Underlying: Common Stock · 55,244 shares Expires 2029-01-31 F1 · derivative.exercise_date: When the ISO and NQ dated 01/31/2019 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 25,000 shares on 01/31/2020 and the balance of 75,000 divided into equal monthly installments thereafter such that the option shall be 100% vested on 01/31/2023. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 21:38 UTC |
SCHLOSSBERG MARK ASVP - Legal & General Counsel
|
GrantIncentive Stock Option (right to buy) · Derivative | 44,756 | $7.03 Strike: $7.03 | $314,634.68 |
DisclosureSEC source: 0001061983-19-000015 · edgardoc.xml · derivative · entry 1 SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,756 Underlying: Common Stock · 44,756 shares Expires 2029-01-31 F1 · derivative.exercise_date: When the ISO and NQ dated 01/31/2019 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 25,000 shares on 01/31/2020 and the balance of 75,000 divided into equal monthly installments thereafter such that the option shall be 100% vested on 01/31/2023. Read SEC document |
| January 10, 2019 Filed Jan 12, 2019 00:00 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $7.31 | $10,965.00 |
DisclosureSEC source: 0001061983-19-000009 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,567 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| January 04, 2019 Filed Jan 4, 2019 22:08 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,000 | $7.11 | $28,432.00 |
DisclosureSEC source: 0001061983-19-000002 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:48 UTC |
PARSHALL B LYNNEDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,582 | $6.82 Strike: $6.82 | $31,249.24 |
DisclosureSEC source: 0001061983-19-000004 · edgardoc.xml · derivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,582 Underlying: Common Stock · 4,582 shares Expires 2029-01-02 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on January 2, 2020. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:49 UTC |
Califf RobertDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,374 | $6.82 Strike: $6.82 | $9,370.68 |
DisclosureSEC source: 0001061983-19-000007 · edgardoc.xml · derivative · entry 1 Califf Robert · CIK 0001574557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,374 Underlying: Common Stock · 1,374 shares Expires 2029-01-02 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on January 2, 2020. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:49 UTC |
HENDERSON JOHN TDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,247 | $6.82 Strike: $6.82 | $56,244.54 |
DisclosureSEC source: 0001061983-19-000006 · edgardoc.xml · derivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,247 Underlying: Common Stock · 8,247 shares Expires 2029-01-02 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on January 2, 2020. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:49 UTC |
Kaye Edward M. MDDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 6,414 | $6.82 Strike: $6.82 | $43,743.48 |
DisclosureSEC source: 0001061983-19-000005 · edgardoc.xml · derivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,414 Underlying: Common Stock · 6,414 shares Expires 2029-01-02 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on January 2, 2020. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:48 UTC |
SMITH SANDFORD DDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,207 | $6.82 Strike: $6.82 | $21,871.74 |
DisclosureSEC source: 0001061983-19-000003 · edgardoc.xml · derivative · entry 1 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,207 Underlying: Common Stock · 3,207 shares Expires 2029-01-02 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on January 2, 2020. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 21:57 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,000 | $7.50 | $29,988.40 |
DisclosureSEC source: 0001061983-18-000056 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 21:56 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $7.38 | $11,070.00 |
DisclosureSEC source: 0001061983-18-000055 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,067 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| November 05, 2018 Filed Nov 6, 2018 16:41 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,000 | $7.11 | $28,446.00 |
DisclosureSEC source: 0001061983-18-000053 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 21:47 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $6.68 | $10,020.00 |
DisclosureSEC source: 0001061983-18-000051 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,567 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| October 05, 2018 Filed Oct 5, 2018 23:23 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,000 | $8.79 | $35,178.00 |
DisclosureSEC source: 0001061983-18-000049 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 15:36 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $9.14 | $13,710.00 |
DisclosureSEC source: 0001061983-18-000047 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,067 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 20:12 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $8.00 | $12,000.00 |
DisclosureSEC source: 0001061983-18-000045 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,567 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 20:11 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,000 | $7.94 | $31,768.80 |
DisclosureSEC source: 0001061983-18-000044 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 21:21 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,000 | $6.65 | $26,582.40 |
DisclosureSEC source: 0001061983-18-000042 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 21:14 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $6.85 | $10,275.00 |
DisclosureSEC source: 0001061983-18-000041 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,067 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 20:33 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,000 | $9.09 | $36,372.40 |
DisclosureSEC source: 0001061983-18-000038 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 20:33 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 1,500 | $9.05 | $13,575.00 |
DisclosureSEC source: 0001061983-18-000039 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,567 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 00:15 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 3,000 | $8.95 | $26,850.00 |
DisclosureSEC source: 0001061983-18-000036 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,067 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 22:11 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,000 | $8.28 | $33,116.40 |
DisclosureSEC source: 0001061983-18-000033 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,022 F1 · kind: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2017. Read SEC document |
| May 16, 2018 Filed May 17, 2018 18:27 UTC |
COSTA SANTO JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $9.45 Strike: $9.45 | $189,000.00 |
DisclosureSEC source: 0001061983-18-000025 · edgardoc.xml · derivative · entry 1 COSTA SANTO J · CIK 0001013419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-05-16 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 16, 2019 Read SEC document |
| May 16, 2018 Filed May 17, 2018 22:29 UTC |
PARSHALL B LYNNEDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $9.45 Strike: $9.45 | $189,000.00 |
DisclosureSEC source: 0001061983-18-000029 · edgardoc.xml · derivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-05-16 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 16, 2019 Read SEC document |
| May 16, 2018 Filed May 17, 2018 22:29 UTC |
WIERENGA WENDALLDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $9.45 Strike: $9.45 | $189,000.00 |
DisclosureSEC source: 0001061983-18-000031 · edgardoc.xml · derivative · entry 1 WIERENGA WENDALL · CIK 0001235945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-05-16 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 16, 2019 Read SEC document |
| May 16, 2018 Filed May 17, 2018 22:29 UTC |
SMITH SANDFORD DDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $9.45 Strike: $9.45 | $189,000.00 |
DisclosureSEC source: 0001061983-18-000030 · edgardoc.xml · derivative · entry 1 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-05-16 F1 · derivative.exercise_date: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 16, 2019 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.